The transaction was completed with a group of strategic investors led by Catheter Precision, Inc. (NYSE:VTAK), the parent company of Flyte, a technology-enabled regional air mobility platform.

The Company issued an aggregate of 6.5 million shares of common stock in the transaction, generating approximately $2.2 million in gross proceeds.